User: Guest  Login
Title:

Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial.

Document type:
Journal Article
Author(s):
Schunkert, Heribert; Boening, Andreas; von Scheidt, Moritz; Lanig, Clarissa; Gusmini, Friederike; de Waha, Antoinette; Kuna, Constantin; Fach, Andreas; Grothusen, Christina; Oberhoffer, Martin; Knosalla, Christoph; Walther, Thomas; Danner, Bernhard C; Misfeld, Martin; Zeymer, Uwe; Wimmer-Greinecker, Gerhard; Siepe, Matthias; Grubitzsch, Herko; Joost, Alexander; Schaefer, Andreas; Conradi, Lenard; Cremer, Jochen; Hamm, Christian; Lange, Rüdiger; Radke, Peter W; Schulz, Rainer; Laufer, Günther; Gr...     »
Abstract:
AIMS: The antiplatelet treatment strategy providing optimal balance between thrombotic and bleeding risks in patients undergoing coronary artery bypass grafting (CABG) is unclear. We prospectively compared the efficacy of ticagrelor and aspirin after CABG. METHODS AND RESULTS: We randomly assigned in double-blind fashion patients scheduled for CABG to either ticagrelor 90 mg twice daily or 100 mg aspirin (1:1) once daily. The primary outcome was the composite of cardiovascular death, myocardial...     »
Journal title abbreviation:
Eur Heart J
Year:
2019
Journal volume:
40
Journal issue:
29
Pages contribution:
2432-2440
Fulltext / DOI:
doi:10.1093/eurheartj/ehz185
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/31145798
Print-ISSN:
0195-668X
TUM Institution:
Klinik für Herz- und Gefäßchirurgie (Prof. Lange); Klinik für Herz- und Kreislauferkrankungen im Erwachsenenalter (Prof. Schunkert)
 BibTeX